Clinical Trial Update: Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)

View source ↗

Summary

This clinical trial update describes the REBORN study, which aims to identify biomarkers for diagnosing neuroendocrine tumors and assessing early treatment resp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Carcinoma
• Neuroendocrine Tumor

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Neuroendocrine Tumors, Neuroendocrine Neoplasm | Status: RECRUITING